3rd Quarter - Report
OGR for AMGEN USA INC
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare Part D and Medicare Part B reimbursement and coverage; drug pricing; PDUFA Reauthorization; H.R.5376, Inflation Reduction Act of 2022 (P.L.117-169); H.R.7667, Food and Drug Amendments of 2022; S.4348; FDASLA Act of 2022; H.R.6833, Making continuing appropriations for fiscal year 2023, and for other purposes (P.L.117-180).
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEAN AGUILLEN | — |
| MOSES MERCADO | — |
| JEROME MURRAY | — |
| KARISSA WILLHITE | — |
Taxation/Internal Revenue Code TAX
Issues related to Puerto Rico; H.R.5376, Inflation Reduction Act of 2022 (P.L.117-169).
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEAN AGUILLEN | — |
| MOSES MERCADO | — |
| JEROME MURRAY | — |
| KARISSA WILLHITE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.